Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 53

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 53
---
 on STAAR if the Merger Is Not Completed If the Merger Agreement is not adopted by STAAR stockholders, or if the Merger is not completed for any other reason:

| • |     | STAAR stockholders will not be entitled to, nor will they receive, any payment for their respective shares of 
 STAAR common stock pursuant to the Merger Agreement;                                                          |

| • |     | STAAR will remain an independent public company, STAAR common stock will continue to be listed and traded on               
 NASDAQ and registered under the Exchange Act, and STAAR will continue to file periodic and other reports with the SEC; and |

| • |     | Under specified circumstances, STAAR will be required to pay Alcon a termination fee of up to $43,425,000, and                 
 Alcon will be required to pay STAAR a termination fee of $72,375,000, as described in “The Merger Agreement—Termination Fees.” |

Merger Consideration Common Stock At the Effective Time, by virtue of the Merger and without any action on the part of Alcon, STAAR, Merger Sub or the STAAR stockholders, each share of STAAR common stock that is issued and outstanding immediately prior to the Effective Time, but excluding Excluded Shares and Dissenting Shares, will be converted automatically into the right to receive the Merger Consideration of $28.00 per share in cash, without interest, subject to any required tax withholding. After the Merger is completed, you will have the right to receive the Merger Consideration in respect of each share of STAAR common stock that you own (other than Excluded Shares and Dissenting Shares) immediately prior to the Effective Time (subject to any required tax withholding), and you will no longer have any rights as a STAAR stockholder (except that STAAR stockholders who properly and validly exercise and do not withdraw their demands for appraisal will have appraisal rights under Section 262). For more information, see “ —Appraisal Rights.” -34-

Treatment of STAAR Long-Term Incentive Awards

STAAR Options. At the Effective Time, each In-the-Money
STAAR Option (whether or not then vested) will be canceled and the holder will be entitled to receive a cash payment equal to (i) the excess of (A) the Merger Consideration over (B) the per share exercise price under such In-the-Money STAAR Option, multiplied by (ii) the total number of